Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ismaël, Elalamy"'
Autor:
Stéphane Zuily, Luc Darnige, Xin Jiang, Tatiana Reshetnyak, Xin-Xin Yan, Zhi-Cheng Jing, Ismaël Elalamy, Maria Vorobyeva, Grigorios Gerotziafas, Denis Wahl, Virginie Dufrost
Publikováno v:
Current rheumatology reports. 22(7)
The efficacy of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS) is discussed. Results from randomized controlled trials are available. It has been stated that a history of arterial thrombosis and triple positivity was associated
Autor:
Stella Salta, Grigorios Gerotziafas, Tatiana Reshetnyak, Ismaël Elalamy, Maria A Satybaldyeva, Virginie Dufrost, Jessie Risse, Stéphane Zuily, Xin-Xin Yan, Yao Du, Denis Wahl, Zhi-Cheng Jing
Publikováno v:
Autoimmunity Reviews. 17:1011-1021
Direct oral anticoagulants (DOACs) are widely used for secondary prevention of venous thromboembolism (VTE) but their clinical efficacy and safety are not established in Antiphospholipid Syndrome (APS) patients. There is only one randomized controlle
Autor:
Brigitte, Séroussi, Houda, Ouarrirh, Ismaël, Elalamy, Grigorios, Gerotziafas, Isabelle, Debrix, Jacques, Bouaud
Publikováno v:
Studies in health technology and informatics. 264
Potentially inappropriate prescribing of direct oral anticoagulants is frequent with the most common errors being dosage, administration, and duration of therapy. We developed RecosDoc-MTeV, a documentary-based clinical decision support system (CDSS)
Publikováno v:
EMC - Angéiologie. 1:1-8